Assignee
STANDARD OF CARE CORP
US·5 granted patents·10 pending applications·4 citations·filing 2020–2024
Top patents by PatentIndex Score
15 records- 0190US10857213B1Hyaluronidase compositions and methods of using same to treat a cosmetic conditionSTANDARD OF CARE CORP·Filed 2020·Granted Dec 8, 2020·3 cites·14 claims
- 0277USD1103382SSurgical drain deviceSTANDARD OF CARE CORP·Filed 2024·Granted Nov 25, 2025·0 cites·1 claims
- 0376US11103183B2Periorbital puffiness assessment scale and methods of use thereofSTANDARD OF CARE CORP·Filed 2020·Granted Aug 31, 2021·1 cites·8 claims
- 0462US2023111020A1Surgical Drain Device and Method of UseSTANDARD OF CARE CORP·Filed 2022·Application pending·0 cites
- 0560US2023200908A1Computing platform for improved aesthetic outcomes and patient safety in medical and surgical cosmetic proceduresSTANDARD OF CARE CORP·Filed 2023·Application pending·0 cites
- 0660US2023200907A1Computing platform for improved aesthetic outcomes and patient safety in medical and surgical cosmetic proceduresSTANDARD OF CARE CORP·Filed 2023·Application pending·0 cites
- 0753US2024009282A1Peri-orbital fullness assessment scale and methods of use thereofSTANDARD OF CARE CORP·Filed 2021·Application pending·0 cites
- 0851US2023012731A1Hyaluronidase compositions and methods of using same to treat peri-orbital hollowness and tear through deformitiesSTANDARD OF CARE CORP·Filed 2020·Application pending·0 cites
- 0950US2023173038A1Aerosolized hyaluronidase and/or 4-methylumbelliferone compositions and methods of using same to treat respiratory diseases or disordersSTANDARD OF CARE CORP·Filed 2021·Application pending·0 cites
- 1048US2023082250A1Hyaluronidase compositions and methods of using same to treat fibrosisSTANDARD OF CARE CORP·Filed 2021·Application pending·0 cites
- 1148US2022409511A1Hyaluronidase compositions and methods of using same to treat celluliteSTANDARD OF CARE CORP·Filed 2020·Application pending·0 cites
- 1248US2024156920A1Compositions comprising hyaluronidase and/or collagenase and/or 4-methylumbelliferone (4-mu) and methods of treatment using sameSTANDARD OF CARE CORP·Filed 2020·Application pending·0 cites
- 1348US2022133861A1Hyaluronidase compositions and methods of using same to treat edemaSTANDARD OF CARE CORP·Filed 2020·Application pending·0 cites
- 1446US11291403B2Hyaluronidase compositions and methods of using same for determining the etiology of peri-orbital puffinessSTANDARD OF CARE CORP·Filed 2020·Granted Apr 5, 2022·0 cites·6 claims
- 1545US11596672B2Hyaluronidase compositions and methods of using same for assessing and/or treating periorbital puffinessSTANDARD OF CARE CORP·Filed 2020·Granted Mar 7, 2023·0 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when STANDARD OF CARE CORP files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →